Concepedia

Weili Li

WL

13

Publications

567

Citations

13

H-Index

2019

Active since

Affiliations

Beijing University of Chinese Medicine(Current)

Guangzhou University of Chinese Medicine

Affiliated Hospital of Shaanxi University of Chinese Medicine

Capital Medical University

Beijing Anzhen Hospital

Weili Li is an author at Beijing University of Chinese Medicine specializing in medicine, cell biology, and inflammation.

ORCID

Top concepts

Publications per year

2019–2024

13

Publications

13

TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity

Xiaoping Wang, Qiyan Wang, Weili Li et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 106 citations · Full text

Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway

Xu Chen, Qiyan Wang, Mingyan Shao et al. · Biomedicine & Pharmacotherapy · 2019 · 86 citations · Full text

Tanshinone IIA Restores Dynamic Balance of Autophagosome/Autolysosome in Doxorubicin-Induced Cardiotoxicity via Targeting Beclin1/LAMP1

Xiaoping Wang, Chun Li, Qiyan Wang et al. · Cancers · 2019 · 74 citations · Full text

, , +20

Danshen (<i>Salvia miltiorrhiza</i>) restricts MD2/TLR4‐MyD88 complex formation and signalling in acute myocardial infarction‐induced heart failure

Xiaoping Wang, Dongqing Guo, Weili Li et al. · Journal of Cellular and Molecular Medicine · 2020 · 61 citations · Full text

Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT–IKK/STAT3 Axis

Xiaoping Wang, Weili Li, Yawen Zhang et al. · Frontiers in Pharmacology · 2022 · 56 citations · Full text

Rows per page

1–5 of 13